Peptide Record

Thymosin beta-4 · full corpus

Explore

Every evidence record, mention, review and regulatory filing collected for Thymosin beta-4, in one list. Each row links to the original. Nothing here is summarised for you — this is the corpus, source tag by source tag.

1,396 records · ordered by source hierarchy — human trials first, vendor material last

Corpus records for Thymosin beta-4
SourceKindRecordAttributionDetailDate
PRECLINICALevidenceHigh expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas.Thymosin β4—2001-07-01
PRECLINICALevidenceSimultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array.Thymosin beta 4Inflammation2001-07-01
PRECLINICALevidenceLocal photorelease of caged thymosin beta4 in locomoting keratocytes causes cell turning.Tbeta4—2001-05-28
PRECLINICALevidenceThymosin beta 4 promotes corneal wound healing and modulates inflammatory mediators in vivo.Thymosin beta 4—2001-05-01
PRECLINICALevidencebeta-Thymosins, small acidic peptides with multiple functions.Thymosin beta 4Wound healing2001-03-01
PRECLINICALevidenceExpression of Thymosin beta4 in Murine Bone Marrow Endothelial Cells, HL-60 Cells and Human Peripheral Blood Mononuclear Cells.Thymosin β4—2001-03-01
PRECLINICALevidenceEarly and progressive accumulation of reactive microglia in the Huntington disease brain.Tbeta4—2001-02-01
PRECLINICALevidenceActin dynamics.Thymosin beta 4—2001-01-01
PRECLINICALevidenceBone marrow endothelial cells secrete thymosin beta4 and AcSDKP.Tbeta4—2001-01-01
PRECLINICALevidenceActin assembly induced by polylysine beads or purified phagosomes: quantitation by a new flow cytometry assay.Thymosin beta 4—2000-09-01
PRECLINICALevidenceMolecular switches in metastasis.Thymosin beta 4—2000-08-03
PRECLINICALevidenceGenomic analysis of metastasis reveals an essential role for RhoC.Thymosin beta 4—2000-08-03
PRECLINICALevidence[The modern approach to wound treatment].Thymosin beta 4Wound healing2000-07-01
PRECLINICALevidencePositive and negative hematopoietic cytokines produced by bone marrow endothelial cells.Thymosin β4Inflammation · preclinical2000-07-01
PRECLINICALevidenceStructural requirements for thymosin beta4 in its contact with actin. An NMR-analysis of thymosin beta4 mutants in solution and correlation with their biological activity.Thymosin beta 4—2000-06-01
PRECLINICALevidenceSequestered actin in chick embryo fibroblasts.Tbeta4Skin appearance & aging2000-06-01
PRECLINICALevidenceThymosin-beta(4) changes the conformation and dynamics of actin monomers.Tbeta4Muscle growth & preservation · preclinical2000-05-01
PRECLINICALevidenceIdentification of known and novel genes in activated monocytes from patients with rheumatoid arthritis.Thymosin β4—2000-04-01
PRECLINICALevidenceEffects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations.Thymosin beta 4—2000-02-18
PRECLINICALevidenceGenes upregulated in the human trabecular meshwork in response to elevated intraocular pressure.Thymosin β4—2000-02-01
PRECLINICALevidence[The effects of cytokines produced by bone marrow endothelial cells on the regulation of hematopoiesis].Thymosin beta 4—2000-02-01
PRECLINICALevidenceInvolvement of ezrin/moesin in de novo actin assembly on phagosomal membranes.Thymosin beta 4—2000-01-17
PRECLINICALevidenceMolecular mechanisms controlling actin filament dynamics in nonmuscle cells.Thymosin beta 4—2000-01-01
PRECLINICALevidenceProfilin promotes barbed-end actin filament assembly without lowering the critical concentration.Thymosin beta 4—1999-12-24
PRECLINICALevidenceThymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids.Thymosin beta 4Inflammation1999-12-01
PRECLINICALevidenceThymosin beta4 accelerates wound healing.Tbeta4Wound healing1999-09-01
PRECLINICALevidenceDecreased thymosin beta4 in apoptosis induced by a variety of antitumor drugs.Thymosin beta 4—1999-05-15
PRECLINICALevidenceHomeostasis, thymic hormones and aging.Thymosin beta 4—1999-05-01
PRECLINICALevidenceDimerization of profilin II upon binding the (GP5)3 peptide from VASP overcomes the inhibition of actin nucleation by profilin II and thymosin beta4.Thymosin beta 4—1999-03-26
PRECLINICALevidencePolyamine depletion alters the relationship of F-actin, G-actin, and thymosin beta4 in migrating IEC-6 cells.Tbeta4Skin appearance & aging1999-02-01
PRECLINICALevidenceThe thymus-pituitary axis and its changes during aging.Thymosin beta 4—1999-01-01
PRECLINICALevidenceInvestigation of the epitopic structure of thymosin beta10 by epitope mapping experiments.Tbeta4—1999-01-01
PRECLINICALevidenceThymosin beta4 enhances endothelial cell differentiation and angiogenesis.Tbeta4—1999-01-01
PRECLINICALevidenceHigh-affinity renal lead-binding proteins in environmentally-exposed humans.Thymosin beta 4—1998-08-14
PRECLINICALevidenceInduction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction.Thymosin beta 4—1998-05-01
PRECLINICALevidencePlant profilin induces actin polymerization from actin : beta-thymosin complexes and competes directly with beta-thymosins and with negative co-operativity with DNase I for binding to actin.Tbeta4—1998-03-27
PRECLINICALevidenceRapid identification and screening of proteins from whole cell lysates of human erythroleukemia cells in the liquid phase, using non-porous reversed phase high-performance liquid chromatography separations of proteins followed by matrix-assisted [correction of multi-assisted] laser desorption/ionization mass spectrometry analysis and sequence database searching.Thymosin beta 4—1998-01-01
PRECLINICALevidenceComparison of the effects of AcSDKP, thymosin beta4, macrophage inflammatory protein 1alpha and transforming growth factor beta on human leukemic cells.Tbeta4Inflammation1997-11-01
PRECLINICALevidenceMapping the binding site of thymosin beta4 on actin by competition with G-actin binding proteins indicates negative co-operativity between binding sites located on opposite subdomains of actin.Thymosin beta 4Muscle growth & preservation · preclinical1997-11-01
PRECLINICALevidenceThe actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells.Thymosin β4—1997-08-15
PRECLINICALevidenceA novel beta-thymosin from the sea urchin: extending the phylogenetic distribution of beta-thymosins from mammals to echinoderms.Thymosin beta 4—1997-07-01
PRECLINICALevidenceA phage display technique for a fast, sensitive, and systematic investigation of protein-protein interactions.Thymosin beta 4—1997-07-01
PRECLINICALevidenceThymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.Thymosin beta 4Wound healing · preclinical1997-05-01
PRECLINICALevidenceA novel thymosin peptide stimulates interleukin-6 release from rat C6 glioma cells in vitro.Thymosin beta 4Inflammation1997-05-01
PRECLINICALevidenceSubtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments.TB4—1997-04-15
PRECLINICALevidenceLow molecular-weight G-actin binding proteins involved in the regulation of actin assembly during myofibrillogenesis.Thymosin beta 4Muscle growth & preservation · preclinical1997-02-01
PRECLINICALevidenceFunctional roles of Phe of deacetyl-thymosin beta4 in the impaired blastogenic response of uraemic T-lymphocytes.Thymosin beta 4—1997-01-01
PRECLINICALevidenceBiodistribution of synthetic thymosin beta 4 in the serum, urine, and major organs of mice.Thymosin beta 4—1997-01-01
PRECLINICALevidenceThymosin beta4, inhibitor for normal hematopoietic progenitor cells.Tbeta4—1996-06-01
PRECLINICALevidenceHigh levels of mouse thymosin beta4 mRNA in differentiating P19 embryonic cells and during development of cardiovascular tissues.Tbeta4Lipid & cardiovascular markers · preclinical1996-05-02